toosendanin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, XL; Tang, JH; Wang, ND; Yan, J; Zhang, Z; Zhao, XH; Zheng, MD | 1 |
| Chen, Y; Cheng, XY; Hua, B; Ji, XJ; Jin, PP; Li, X; Liu, YJ; Ma, L; Yin, F; Yin, W; You, M; Zhang, ZX; Zhou, R | 1 |
2 other study(ies) available for toosendanin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Toosendanin mediates cisplatin sensitization through targeting Annexin A4/ATP7A in non-small cell lung cancer cells.
Topics: Annexin A4; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drugs, Chinese Herbal; Humans; Lung Neoplasms; Multidrug Resistance-Associated Protein 2; Transfection | 2018 |
Reversal of the Apoptotic Resistance of Non-Small-Cell Lung Carcinoma towards TRAIL by Natural Product Toosendanin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Calcium; Carcinoma, Non-Small-Cell Lung; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Humans; Lung Neoplasms; Mice; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2017 |